Interestingly, FBXO3 promotes the ubiquitylation and degradation of ΔNp63α to enhance TGF-β signaling and accelerate tumor metastasis, indicating that FBXO3 may be a potential therapeutic target for advanced breast cancer treatment [39]. This evidence concerns the gene FBXO3 and neoplasm.